PA
GRDN

Parallel Advisors’s Guardian Pharmacy Services GRDN Stock Holding History

Parallel Advisors’s Portfolio GRDN Stock Details GRDN Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$502 Hold
12
– – ﹤0.01% 3791
2026
Q1 		$452 Buy
+12
New +$392 ﹤0.01% 3686

Other funds holding GRDN

Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $580B AUM 38.23% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
WP
Woodline Partners San Francisco, California $32.4B AUM 58.5% 1-Year Est. Return
VCM
Valiant Capital Management San Francisco, California $2.48B AUM 57.08% 1-Year Est. Return
T. Rowe Price Investment Management
T. Rowe Price Investment Management Baltimore, Maryland $153B AUM 38.14% 1-Year Est. Return
Boston Partners
Boston Partners Boston, Massachusetts $113B AUM 38.87% 1-Year Est. Return
Franklin Resources
Franklin Resources San Mateo, California $462B AUM 39.16% 1-Year Est. Return
TCM
TimesSquare Capital Management New York $6.8B AUM 45.85% 1-Year Est. Return

Parallel Advisors's GRDN Position: Q2 2026 in Review

Parallel Advisors held its Guardian Pharmacy Services (GRDN) position steady in Q2 2026 at 12 shares worth $502. The position accounts for ﹤0.01% of the portfolio, ranked #3791.

Parallel Advisors first reported a position in GRDN in Q1 2026 and has held it in 2 quarters since. 190 funds tracked by Wall St. Rank hold GRDN as of Q2 2026.

  • Parallel Advisors held 12 shares of Guardian Pharmacy Services worth $502 as of Q2 2026.
  • Parallel Advisors left its Guardian Pharmacy Services share count unchanged in Q2 2026.
  • Guardian Pharmacy Services made up ﹤0.01% of Parallel Advisors's portfolio in Q2 2026, its #3791 holding.
  • Parallel Advisors first reported a position in Guardian Pharmacy Services in Q1 2026 and has held it in 2 quarters since.
  • 190 funds tracked by Wall St. Rank held Guardian Pharmacy Services as of Q2 2026.

Based on Parallel Advisors's 13F filing for Q2 2026, filed 5 Aug 2026.